Huntingtonʼs disease
Authors:
- Victor S.C. FungVFVictor S.C. Fung
- 1 August 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 25 (4) , 491-498
Abstract
This review highlights the recent advances in Huntington's disease, with particular focus on clinical characterization of prodromal Huntington's disease, as well as the growing literature regarding pathophysiological mechanisms and their relevance to potential therapeutic targets. Clinical and neuroradiological abnormalities can be demonstrated in gene-positive individuals prior to the onset of manifest Huntington's disease, even as far as 15 years before the disease onset. Although some measures show promise as potential markers of disease progression, further longitudinal studies are required. Several molecular pathways have been implicated in the process of neurodegeneration involved in Huntington's disease and provide potential therapeutic targets. With predictive testing allowing the identification of gene-positive individuals prior to disease onset, the prodromal stage of Huntington's disease provides an ideal period for the use of disease-modifying therapy. A quantifiable and reliable biomarker for monitoring disease progression is crucial for clinical studies of neuroprotection, and this remains an area of active research. Understanding of the underlying pathophysiological mechanisms continues to grow, based mainly on cellular and animal models of Huntington's disease.Keywords
This publication has 78 references indexed in Scilit:
- Biological markers of cognition in prodromal Huntington’s disease: A reviewBrain and Cognition, 2011
- Cognitive Impairment in Huntington Disease: Diagnosis and TreatmentCurrent Neurology and Neuroscience Reports, 2011
- Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington diseaseJournal of Neurology, 2011
- Suicidal Behavior in Prodromal Huntington DiseaseNeurodegenerative Diseases, 2011
- Neurocognitive signs in prodromal Huntington disease.Neuropsychology, 2011
- Tapping linked to function and structure in premanifest and symptomatic Huntington diseaseNeurology, 2010
- Mild cognitive impairment in prediagnosed Huntington diseaseNeurology, 2010
- Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's diseaseMovement Disorders, 2010
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline dataThe Lancet Neurology, 2009
- A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG lengthClinical Genetics, 2004